February 17, 2021
“Yields on some Treasury bills—short-term securities that mature in a year or less—could temporarily turn negative because of a coming supply crunch, experts say. While they won’t be auctioned by the U.S. at rates below zero, as auction rules prevent that, bills… Continue Reading…
February 9, 2021
“Guild Holdings (GHLD)… …4 Buys and 1 Hold assigned in the last three months add up to a Strong Buy analyst consensus. The stock is selling for $16.21, and its $19.30 average price target implies a 19% one-year upside… PDC Energy (PDCE)…… Continue Reading…
January 21, 2021
“AzurRx BioPharma (AZRX)… Overall, the analyst consensus on AZRX shares is a Strong Buy; the stock has 4 recent reviews, including 3 Buys and a single Hold. In addition, the $4 average price target brings the upside potential to 304%…… Continue Reading…
January 13, 2021
“AcelRx Pharmaceuticals (ACRX)… Turning now to the rest of the Street, 3 Buys and no Holds or Sells have been published in the last three months. Therefore, ACRX has a Strong Buy consensus rating. Based on the $7 average price target,… Continue Reading…
January 8, 2021
“…“We’re still working through the models because we don’t have visibility around the timing of [legislation] but we would anticipate either the back half of ’21 or the first half of ’22,” Azer said. “But what we have asserted is… Continue Reading…
January 7, 2021
“An improving economic backdrop, higher sales and earnings, and less of a need for companies to hoard cash could bring a surge in dividends and buybacks this year. Goldman Sachs analysts see S&P 500 dividends rising by 5% and buybacks climbing 15% in 2021…”… Continue Reading…
January 6, 2021
“9 Meters Biopharma (NMTR)… Turning now to the rest of the Street, other analysts are on the same page. With 4 Buys and no Holds or Sells, the word on the Street is that NMTR is a Strong Buy. Given… Continue Reading…
December 28, 2020
“Even though U.S. stocks are at all-time highs today, market strategists see the S&P 500 index rising further in 2021, propelled by a stronger economy, robust profit growth, and still-massive stimulus from governments and central banks, which paved the way… Continue Reading…
December 23, 2020
“Shell (ticker: RDS.B) stock is down 42% this year, worse than the Energy Select Sector SPD exchange-traded fund (XLE), which is off by 33%. But MKM Partners analyst John Gerdes says Shell shares could rebound by 68% as the company gets leaner… Continue Reading…
December 10, 2020
“Turning Point Brands (TPB)… Overall, the Strong Buy consensus rating on Turning Points Brands is unanimous, standing on 5 Buy-side reviews. The stock is selling for $42.60, and its $46.46 average price target implies ~9% upside from current levels… Gladstone Lands… Continue Reading…
Recent Comments